Why Tonix Pharmaceuticals Rocketed 33% Higher Today


A big regulatory win was reaping huge prizes for Tonix Pharmaceuticals (NASDAQ: TNXP) on Thursday. Following a new nod from the Food and Drug Administration (FDA) for one of its leading pipeline drugs, the biotech’s shares went on a quick trip skyward, rising 33% in price on the day.

Read more: https://www.nasdaq.com/articles/why-tonix-pharmaceuticals-rocketed-33-higher-today